 |
Customized monoclonal and polyclonal
anitbodies. |
|
|
Cloning of
antibody genes into suitable expression
vectors. |
|
|
Selection
and expression of antibody producing cell
lines. |
|
| |
Pilot scale
cell culture for antibody production. |
|
|
Downstream
process development for antibody purification. |
|
|
Characterization of antibodies. |
|
|
Bulk
supplies of antibodies. |
|
Humanized antibodies. |
|
|
Peptide
design and synthesis. |
|
|
SiRNA and
Biomarkers. |
|
| |
Development
and expression of recombinant protiens. |
|
|
Assay
development - ELISA, Western blot,
Immunohistochemistry & Microarrays. |
|
|
Cell
banking facility. |
|
|
Pre-clinical
drug research & development. |
|
| Our clients |
|
University of Pennsylvania,
USA |
|
|
University of California,
San Francisco, USA |
|
|
Emory University,
Atlanta, USA |
|
|
Hebrew University School
of Medicine, Israel |
|
|
University
of Glasgow, UK |
|
|
University of Bath, UK |
|
|
University of Sussex,
UK |
|
|
Genome Data
Systems, New Jersey, USA |
|
|
Golgene
Technology, Leeds, UK |
|
University
of Cardiff, Wales, UK |
|
|
Gentaur,
Belgium |
|
|
Yashraj
Biotechnology, Mumbai, India |
|
|
National
Center for Biological Sciences(NCBS), Banglore,
India |
|
|
National
Center for Plant Genomic Research(NCPGR), New
Delhi, India |
|
|
Centre for
DNA Fingerprinting and Diagnostics(CDFD),
Hyderabad, India |
|
|
Central
Drug Research Institute(CDRI), Lucknow, India |
|
|
Jawaharlal Nehru University(JNU),
India |
|
|
Tata Institute of Fundamental
Research(TIFR), India |
|
Institute
of Microbial Technology(IMTECH), Chandigarh, India |
|
Antibodies available |
|
|
| |
| Some
of the proteins against which we have
mAbs available currently include the
following: |
| Glycodelin(earlier
called PP14) |
Insulin |
hCG |
| Bid |
Bcl-2 |
Caspase 3 |
| Caspase 8 |
TNF-alpha |
FAS-R |
| GFP |
GST |
|
|
